UniProt ID | RL7_HUMAN | |
---|---|---|
UniProt AC | P18124 | |
Protein Name | 60S ribosomal protein L7 | |
Gene Name | RPL7 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 248 | |
Subcellular Localization | ||
Protein Description | Component of the large ribosomal subunit. [PubMed: 12962325 Binds to G-rich structures in 28S rRNA and in mRNAs. Plays a regulatory role in the translation apparatus; inhibits cell-free translation of mRNAs.] | |
Protein Sequence | MEGVEEKKKEVPAVPETLKKKRRNFAELKIKRLRKKFAQKMLRKARRKLIYEKAKHYHKEYRQMYRTEIRMARMARKAGNFYVPAEPKLAFVIRIRGINGVSPKVRKVLQLLRLRQIFNGTFVKLNKASINMLRIVEPYIAWGYPNLKSVNELIYKRGYGKINKKRIALTDNALIARSLGKYGIICMEDLIHEIYTVGKRFKEANNFLWPFKLSSPRGGMKKKTTHFVEGGDAGNREDQINRLIRRMN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MEGVEEKK -------CCCHHHHH | 10.24 | 12962325 | |
7 | Ubiquitination | -MEGVEEKKKEVPAV -CCCHHHHHHCCCCC | 56.49 | 33845483 | |
8 | Ubiquitination | MEGVEEKKKEVPAVP CCCHHHHHHCCCCCC | 58.40 | 27667366 | |
9 | Ubiquitination | EGVEEKKKEVPAVPE CCHHHHHHCCCCCCH | 75.02 | 32015554 | |
13 | Ubiquitination | EKKKEVPAVPETLKK HHHHCCCCCCHHHHH | 34.37 | 27667366 | |
15 | Ubiquitination | KKEVPAVPETLKKKR HHCCCCCCHHHHHHH | 30.84 | 22817900 | |
17 | Phosphorylation | EVPAVPETLKKKRRN CCCCCCHHHHHHHCC | 37.50 | 30266825 | |
19 | Acetylation | PAVPETLKKKRRNFA CCCCHHHHHHHCCHH | 64.76 | 23236377 | |
19 | Ubiquitination | PAVPETLKKKRRNFA CCCCHHHHHHHCCHH | 64.76 | 27667366 | |
19 | Succinylation | PAVPETLKKKRRNFA CCCCHHHHHHHCCHH | 64.76 | 23954790 | |
20 | Ubiquitination | AVPETLKKKRRNFAE CCCHHHHHHHCCHHH | 55.41 | 33845483 | |
21 | Ubiquitination | VPETLKKKRRNFAEL CCHHHHHHHCCHHHH | 55.81 | 23503661 | |
29 | Acetylation | RRNFAELKIKRLRKK HCCHHHHHHHHHHHH | 37.37 | 23236377 | |
29 | Ubiquitination | RRNFAELKIKRLRKK HCCHHHHHHHHHHHH | 37.37 | 23000965 | |
31 | Acetylation | NFAELKIKRLRKKFA CHHHHHHHHHHHHHH | 43.74 | - | |
31 | Ubiquitination | NFAELKIKRLRKKFA CHHHHHHHHHHHHHH | 43.74 | 23000965 | |
35 | Ubiquitination | LKIKRLRKKFAQKML HHHHHHHHHHHHHHH | 57.76 | 23000965 | |
36 | Ubiquitination | KIKRLRKKFAQKMLR HHHHHHHHHHHHHHH | 39.23 | 23000965 | |
37 | Ubiquitination | IKRLRKKFAQKMLRK HHHHHHHHHHHHHHH | 11.05 | 23000965 | |
40 | Ubiquitination | LRKKFAQKMLRKARR HHHHHHHHHHHHHHH | 36.15 | 23000965 | |
40 | Acetylation | LRKKFAQKMLRKARR HHHHHHHHHHHHHHH | 36.15 | 25825284 | |
44 | Ubiquitination | FAQKMLRKARRKLIY HHHHHHHHHHHHHHH | 42.14 | 23000965 | |
48 | Ubiquitination | MLRKARRKLIYEKAK HHHHHHHHHHHHHHH | 33.41 | 23000965 | |
48 | Acetylation | MLRKARRKLIYEKAK HHHHHHHHHHHHHHH | 33.41 | 26051181 | |
51 | Phosphorylation | KARRKLIYEKAKHYH HHHHHHHHHHHHHHH | 23.09 | 28152594 | |
53 | Ubiquitination | RRKLIYEKAKHYHKE HHHHHHHHHHHHHHH | 45.85 | 21906983 | |
53 | Acetylation | RRKLIYEKAKHYHKE HHHHHHHHHHHHHHH | 45.85 | 26051181 | |
55 | Ubiquitination | KLIYEKAKHYHKEYR HHHHHHHHHHHHHHH | 56.62 | 33845483 | |
59 | Acetylation | EKAKHYHKEYRQMYR HHHHHHHHHHHHHHH | 49.64 | 26051181 | |
59 | Ubiquitination | EKAKHYHKEYRQMYR HHHHHHHHHHHHHHH | 49.64 | 23503661 | |
64 | Ubiquitination | YHKEYRQMYRTEIRM HHHHHHHHHHHHHHH | 1.48 | 23000965 | |
67 | Ubiquitination | EYRQMYRTEIRMARM HHHHHHHHHHHHHHH | 20.48 | 23000965 | |
77 | Ubiquitination | RMARMARKAGNFYVP HHHHHHHHCCCEEEC | 51.62 | 23000965 | |
82 | Phosphorylation | ARKAGNFYVPAEPKL HHHCCCEEECCCCCE | 14.99 | 28152594 | |
84 | Ubiquitination | KAGNFYVPAEPKLAF HCCCEEECCCCCEEE | 21.37 | 23000965 | |
87 | Ubiquitination | NFYVPAEPKLAFVIR CEEECCCCCEEEEEE | 38.78 | 23000965 | |
88 | Ubiquitination | FYVPAEPKLAFVIRI EEECCCCCEEEEEEE | 43.91 | 23000965 | |
88 | Acetylation | FYVPAEPKLAFVIRI EEECCCCCEEEEEEE | 43.91 | 26051181 | |
96 | Methylation | LAFVIRIRGINGVSP EEEEEEECCCCCCCH | 30.04 | 115492247 | |
102 | Phosphorylation | IRGINGVSPKVRKVL ECCCCCCCHHHHHHH | 22.02 | 28985074 | |
104 | Ubiquitination | GINGVSPKVRKVLQL CCCCCCHHHHHHHHH | 47.36 | 23000965 | |
107 | Ubiquitination | GVSPKVRKVLQLLRL CCCHHHHHHHHHHHH | 50.73 | 23000965 | |
108 | Ubiquitination | VSPKVRKVLQLLRLR CCHHHHHHHHHHHHH | 2.63 | 21963094 | |
116 | Ubiquitination | LQLLRLRQIFNGTFV HHHHHHHHHHCCCEE | 49.57 | 23000965 | |
121 | Ubiquitination | LRQIFNGTFVKLNKA HHHHHCCCEEECCHH | 26.76 | 23000965 | |
124 | Acetylation | IFNGTFVKLNKASIN HHCCCEEECCHHHCC | 42.00 | 19608861 | |
124 | Ubiquitination | IFNGTFVKLNKASIN HHCCCEEECCHHHCC | 42.00 | 23000965 | |
124 | Methylation | IFNGTFVKLNKASIN HHCCCEEECCHHHCC | 42.00 | 22647069 | |
127 | Succinylation | GTFVKLNKASINMLR CCEEECCHHHCCCHH | 54.68 | 21890473 | |
127 | Acetylation | GTFVKLNKASINMLR CCEEECCHHHCCCHH | 54.68 | 25953088 | |
127 | Succinylation | GTFVKLNKASINMLR CCEEECCHHHCCCHH | 54.68 | - | |
127 | Ubiquitination | GTFVKLNKASINMLR CCEEECCHHHCCCHH | 54.68 | 23000965 | |
129 | Phosphorylation | FVKLNKASINMLRIV EEECCHHHCCCHHHC | 18.99 | 27251275 | |
132 | Sulfoxidation | LNKASINMLRIVEPY CCHHHCCCHHHCCCH | 2.25 | 21406390 | |
134 | Methylation | KASINMLRIVEPYIA HHHCCCHHHCCCHHH | 21.82 | 115492239 | |
139 | Phosphorylation | MLRIVEPYIAWGYPN CHHHCCCHHHCCCCC | 6.97 | 28152594 | |
141 | Ubiquitination | RIVEPYIAWGYPNLK HHCCCHHHCCCCCHH | 6.44 | 21963094 | |
144 | Phosphorylation | EPYIAWGYPNLKSVN CCHHHCCCCCHHHHH | 4.35 | 28152594 | |
148 | Ubiquitination | AWGYPNLKSVNELIY HCCCCCHHHHHHHHH | 60.02 | 21906983 | |
148 | Methylation | AWGYPNLKSVNELIY HCCCCCHHHHHHHHH | 60.02 | 30793667 | |
149 | Phosphorylation | WGYPNLKSVNELIYK CCCCCHHHHHHHHHH | 33.08 | 21712546 | |
155 | Phosphorylation | KSVNELIYKRGYGKI HHHHHHHHHCCCCCC | 13.78 | 28152594 | |
156 | Ubiquitination | SVNELIYKRGYGKIN HHHHHHHHCCCCCCC | 32.14 | 23000965 | |
156 | Acetylation | SVNELIYKRGYGKIN HHHHHHHHCCCCCCC | 32.14 | 26051181 | |
156 | Methylation | SVNELIYKRGYGKIN HHHHHHHHCCCCCCC | 32.14 | 66702645 | |
159 | Ubiquitination | ELIYKRGYGKINKKR HHHHHCCCCCCCHHH | 21.19 | 21963094 | |
159 | Phosphorylation | ELIYKRGYGKINKKR HHHHHCCCCCCCHHH | 21.19 | 20068231 | |
161 | Ubiquitination | IYKRGYGKINKKRIA HHHCCCCCCCHHHEE | 34.32 | 23000965 | |
161 | Acetylation | IYKRGYGKINKKRIA HHHCCCCCCCHHHEE | 34.32 | 19608861 | |
162 | Ubiquitination | YKRGYGKINKKRIAL HHCCCCCCCHHHEEE | 8.74 | 21963094 | |
164 | Ubiquitination | RGYGKINKKRIALTD CCCCCCCHHHEEECC | 47.07 | 24816145 | |
170 | Phosphorylation | NKKRIALTDNALIAR CHHHEEECCCHHHHH | 20.41 | 21712546 | |
172 | Ubiquitination | KRIALTDNALIARSL HHEEECCCHHHHHHH | 31.26 | 21890473 | |
181 | Ubiquitination | LIARSLGKYGIICME HHHHHHHHCEEEEHH | 45.67 | 21963094 | |
182 | Phosphorylation | IARSLGKYGIICMED HHHHHHHCEEEEHHH | 16.26 | 26126808 | |
182 | Ubiquitination | IARSLGKYGIICMED HHHHHHHCEEEEHHH | 16.26 | 22505724 | |
183 | Ubiquitination | ARSLGKYGIICMEDL HHHHHHCEEEEHHHH | 13.28 | 21963094 | |
195 | Phosphorylation | EDLIHEIYTVGKRFK HHHHHHHHHHHHHHH | 7.74 | 19060867 | |
196 | Phosphorylation | DLIHEIYTVGKRFKE HHHHHHHHHHHHHHH | 28.57 | 26126808 | |
199 | Acetylation | HEIYTVGKRFKEANN HHHHHHHHHHHHHHC | 50.77 | 26051181 | |
199 | Ubiquitination | HEIYTVGKRFKEANN HHHHHHHHHHHHHHC | 50.77 | 21906983 | |
202 | Acetylation | YTVGKRFKEANNFLW HHHHHHHHHHHCCCC | 61.01 | 26051181 | |
202 | Methylation | YTVGKRFKEANNFLW HHHHHHHHHHHCCCC | 61.01 | 42367625 | |
202 | Ubiquitination | YTVGKRFKEANNFLW HHHHHHHHHHHCCCC | 61.01 | 21963094 | |
212 | Ubiquitination | NNFLWPFKLSSPRGG HCCCCCEECCCCCCC | 43.30 | 21963094 | |
212 | Acetylation | NNFLWPFKLSSPRGG HCCCCCEECCCCCCC | 43.30 | 26051181 | |
214 | Phosphorylation | FLWPFKLSSPRGGMK CCCCEECCCCCCCCC | 38.60 | 28450419 | |
215 | Phosphorylation | LWPFKLSSPRGGMKK CCCEECCCCCCCCCC | 29.11 | 28450419 | |
217 | Methylation | PFKLSSPRGGMKKKT CEECCCCCCCCCCCE | 57.13 | 115492255 | |
221 | Ubiquitination | SSPRGGMKKKTTHFV CCCCCCCCCCEEEEE | 55.16 | 24816145 | |
222 | Ubiquitination | SPRGGMKKKTTHFVE CCCCCCCCCEEEEEC | 46.60 | 22505724 | |
223 | Ubiquitination | PRGGMKKKTTHFVEG CCCCCCCCEEEEECC | 53.81 | 21906983 | |
224 | Phosphorylation | RGGMKKKTTHFVEGG CCCCCCCEEEEECCC | 34.09 | 23312004 | |
225 | Phosphorylation | GGMKKKTTHFVEGGD CCCCCCEEEEECCCC | 23.38 | 23312004 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RL7_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RL7_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RL7_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
"Characterization and analysis of posttranslational modifications ofthe human large cytoplasmic ribosomal subunit proteins by massspectrometry and Edman sequencing."; Odintsova T.I., Muller E.C., Ivanov A.V., Egorov T.A., Bienert R.,Vladimirov S.N., Kostka S., Otto A., Wittmann-Liebold B.,Karpova G.G.; J. Protein Chem. 22:249-258(2003). Cited for: MASS SPECTROMETRY, AND PROBABLE ACETYLATION AT MET-1. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-29; LYS-31; LYS-124 ANDLYS-161, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-139 AND TYR-195, ANDMASS SPECTROMETRY. |